[1]
V. C. Hellström, “Malignancies in transplanted patients: Multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation – experiences from a prospective, clinical, observational study”, AO, vol. 55, no. 6, pp. 774–781, Jun. 2016.